Chemokine C‐C motif receptor 5 and C‐C motif ligand 5 promote cancer cell migration under hypoxia
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The chemokine CC motif receptor 5 (CCR 5) and its ligands have been reported to be associated with cancer progression and metastasis. Although recent researches have demonstrated a fundamental role of hypoxia in cancer, the effect of hypoxia on the expression and function of CCR 5 and its ligands in cancer cells is unknown. Here, we investigated the status of CCR 5 and its ligands in cancer cells under hypoxic conditions. Quantitative polymerase chain reaction, western blotting and immunofluorescence staining showed that hypoxia induced a strong increase of CCR 5 expression. Dual luciferase assay and m RNA stability analysis indicated that hypoxia‐induced CCR 5 m RNA expression relied on both transcriptional and posttranscriptional mechanisms. We detected the expression of CCR 5 ligands and found that chemokine CC motif ligand 5 (CCL 5) was induced under hypoxia. Recombinant human CCL 5 stimulated cell migration rather than cell proliferation under hypoxia, and neutralization of CCL 5 inhibited hypoxia‐induced migration of cancer cells. Similarly, overexpression of CCR 5 increased cell migration, and knockdown of CCR 5 attenuated hypoxia‐mediated cell migration. We further showed that hypoxia‐inducible factor‐1α (HIF‐1α) was involved in CCR 5 and CCL 5 regulation under hypoxia. HIF‐1α m RNA levels were highly correlated with CCR 5 m RNA and CCL 5 m RNA levels in clinical samples. CCR 5 and CCL 5 were highly expressed in breast cancer lymph nodes metastases. Taken together, our data suggest that CCR 5‐CCL 5 interaction promotes cancer cell migration under hypoxia. (Cancer Sci 2012; 103: 904–912)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723
Cited by
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195
“For instance, CCL5 and C-X-C motif chemokine 12 (CXCL12, also known as SDF1a) production by hypoxic tumor cells is driven by HIF-1a (Du et al., 2008; Lin et al., 2012), and chemokine receptor C-X-C motif chemokine receptor (CXCR4) expression by myeloid and tumor cells is regulated by the VHL-HIF…”
BackgroundThe Inflammatory Chemokine CCL5 and Cancer Progression
Aldinucci, D., & Colombatti, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/292376 · Cited by 438
The stimulation of thrombosis by hypoxia
Gupta, N., Zhao, Y.-Y., & Evans, C. E. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.07.013 · Cited by 435
The CCL5/CCR5 Axis in Cancer Progression
Aldinucci, D., Borghese, C., & Casagrande, N. (2020) · Cancers · doi:10.3390/cancers12071765 · Cited by 400
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
Chouaib, S., Noman, M. Z., Kosmatopoulos, K., & Curran, M. A. (2017) · Oncogene · doi:10.1038/onc.2016.225 · Cited by 365
Metadata
- Authors
- Lin, S., Wan, S., Sun, L., Hu, J., Fang, D., Zhao, R., Yuan, S., & Zhang, L.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2012-04-12
- Volume
- 103
- Issue
- 5
- Pages
- 904-912
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2064964116
- Cited by
- 92
- References
- 4
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.